| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Cell and Tumor Biology |
1 Department of Pharmacology, Faculty of Medicine, The University of Hong Kong and 2 School of Chinese Medicine, Hong Kong Baptist University, Hong Kong, China
Requests for reprints: Chi H. Cho, Department of Pharmacology, The University of Hong Kong, 21 Sassoon Road, Hong Kong, China. Phone: 852-2819-9250; Fax: 852-2817-0859; E-mail: chcho{at}hkusua.hku.hk.
Cigarette smoking is a risk factor for colorectal cancer. It is suggested that 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone (NNK), a tobacco-specific nitrosamine, mediates the carcinogenic action of cigarette smoking by promoting cancer growth. In the present study, the proliferative response of a cultured colon cancer cell line HT-29 to NNK was determined. It was found that NNK dose-dependently stimulated HT-29 cell proliferation. In this regard, the stimulatory action of NNK was abolished by atenolol and ICI 118,551, a ß1- and ß2-selective antagonist, respectively. In addition, cell growth was stimulated by the nonselective adrenergic agonist, noradrenaline, and more effectively by the ß-selective agonist, isoproterenol. The second message cyclic AMP level for ß-adrenoceptor activation was elevated by isoproterenol and NNK treatment. These agents also up-regulated cyclooxygenase-2 expression, cytosolic phospholipase A2 expression, and prostaglandin E2 release. ß2-adrenoceptor blockade with ICI 118,551, in contrast, significantly decreased cyclooxygenase-2 expression, cytosolic phospholipase A2 expression and prostaglandin E2 release induced by NNK and isoproterenol. To conclude, it is proposed that NNK stimulates HT-29 cell proliferation through ß-adrenoceptors, preferentially ß2 receptors. Activation of the ß-adrenoceptors, and the consequent cyclic AMP elevation coupled with the downstream arachidonic acid pathway, is perhaps an important mechanistic cascade in the promotion of colon cancer growth. These findings partly elucidate the carcinogenic actions of cigarette smoke and shed new light on the novel modulatory role of ß-adrenoceptors in the development of colon cancer.
This article has been cited by other articles:
![]() |
X. Liu, W. K. K. Wu, L. Yu, Z. J. Li, J. J. Y. Sung, S. T. Zhang, and C. H. Cho Epidermal Growth Factor-Induced Esophageal Cancer Cell Proliferation Requires Transactivation of {beta}-Adrenoceptors J. Pharmacol. Exp. Ther., July 1, 2008; 326(1): 69 - 75. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. Mastrangelo, A. Cassidy, F. Mulholland, W. Wang, and Y. Bao Serotonin Receptors, Novel Targets of Sulforaphane Identified by Proteomic Analysis in Caco-2 Cells Cancer Res., July 1, 2008; 68(13): 5487 - 5491. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. P. S. Wong, L. Yu, E. K. Y. Lam, E. K. K. Tai, W. K. K. Wu, and C.-H. Cho Nicotine Promotes Colon Tumor Growth and Angiogenesis through {beta}-Adrenergic Activation Toxicol. Sci., June 1, 2007; 97(2): 279 - 287. [Abstract] [Full Text] [PDF] |
||||
![]() |
V. Y. Shin, W. K. K. Wu, K. M. Chu, M. W. L. Koo, H. P. S. Wong, E. K. Y. Lam, E. K. K. Tai, and C. H. Cho Functional Role of {beta}-Adrenergic Receptors in the Mitogenic Action of Nicotine on Gastric Cancer Cells Toxicol. Sci., March 1, 2007; 96(1): 21 - 29. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Cancer Research | Clinical Cancer Research |
| Cancer Epidemiology Biomarkers & Prevention | Molecular Cancer Therapeutics |
| Molecular Cancer Research | Cancer Prevention Research |
| Cancer Prevention Journals Portal | Cancer Reviews Online |
| Annual Meeting Education Book | Meeting Abstracts Online |